CADTH Reimbursement Review Dexamethasone Intravitreal Implant (Ozurdex) - Sponsor: Allergan, an AbbVie Company

Canadian Agency for Drugs and Technologies in Health

Share artifact

Or copy link:

Register Login

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Accessing this content requires a membership

Check your affiliation Start a trial

If your institution is a member, please log into Canada Commons from a link provided by your institution. This typically involves logging in via a menu managed by your library.

Add to list

You have no lists yet

Manage lists

Citation

Health, C., 2023. CADTH Reimbursement Review Dexamethasone Intravitreal Implant (Ozurdex) - Sponsor: Allergan, an AbbVie Company, Canadian Agency for Drugs and Technologies in Health. Canada. Retrieved from https://canadacommons.ca/artifacts/3757683/cadth-reimbursement-review-dexamethasone-intravitreal-implant-ozurdex-sponsor/4563178/ on 18 May 2024. CID: 20.500.12592/nb4j5t.

Download citation (RIS)

Full-page Screenshot

Screenshot of https://coherent-commons.s3.amazonaws.com/artifacts/file/file/341bd311-7719-4a2f-a660-d664936ce5a2.pdf?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIA23B6R4NTCRHS5NZ3%2F20240518%2Fus-east-2%2Fs3%2Faws4_request&X-Amz-Date=20240518T151345Z&X-Amz-Expires=3600&X-Amz-SignedHeaders=host&X-Amz-Signature=f67d348fd90c72b6eb0178dcb0df2661153c3cd97ecab51f083eab04591c5ced

CADTH Reimbursement Review Dexamethasone Intravitreal Implant (Ozurdex) - Sponsor: Allergan, an AbbVie Company

Authors

Tables

Share artifact

Add to list

Citation

Full-page Screenshot